AKI | Severe AKI (KDIGO 2–3) | RRT | 90-day mortality | |
---|---|---|---|---|
Goodness of fita (clinical risk model) | 0.406 | 0.400 | 0.973 | 0.365 |
Goodness of fita (new model including uNGAL) | 0.395 | 0.338 | 0.749 | 0.990 |
Events (n) | 217 | 134 | 46 | 136 |
Nonevents (n) | 267 | 350 | 438 | 348 |
AUC | ||||
uNGAL alone | 0.690 (0.647 to 0.731) | 0.728 (0.686 to 0.767) | 0.769 (0.729 to 0.806) | 0.600 (0.555 to 0.644) |
Clinical risk model | 0.717 (0.670 to 0.764) | 0.759 (0.710 to 0.809) | 0.724 (0.643 to 0.805) | 0.797 (0.754 to 0.840) |
New risk model (uNGAL added) | 0.749 (0.704 to 0.794) | 0.799 (0.755 to 0.843) | 0.824 (0.761 to 0.886) | 0.804 (0.762 to 0.846) |
Difference, p (clinical model vs new model) | 0.017 | 0.011 | 0.005 | 0.27 |
Category-free NRI (%) | ||||
cfNRIevents | 1.38 (− 12 to 14.77) | 22.39 (6.11 to 38.67) | 47.83 (21.91 to 73.74) | − 4.41 (− 21.06 to 12.23) |
cfNRInonevents | 48.69 (38.25 to 59.13) | 49.14 (39.99 to 58.29) | 46.58 (38.54 to 54.62) | 34.48 (24.67 to 44.3) |
cfNRI | 50.07 (33.01 to 67.13) | 71.53 (52.88 to 90.19) | 94.4 (67.16 to 121.65) | 30.07 (10.71 to 49.43) |
IDI and summary statistics | ||||
IDIevents | 0.0248 (0.0099 to 0.0398) | 0.0398 (0.0185 to 0.061) | 0.0615 (0.0361 to 0.0868) | 0.0115 (− 0.0003 to 0.0233) |
IDInonevents | 0.0202 (0.0092 to 0.0312) | 0.0152 (0.0049 to 0.0256) | 0.0065 (− 0.0007 to 0.0136) | 0.0045 (− 0.0008 to 0.0099) |
IDI | 0.045 (0.0264 to 0.0637) | 0.055 (0.0317 to 0.0782) | 0.0679 (0.0413 to 0.0945) | 0.016 (0.0032 to 0.0289) |
ISold | 0.5263 (0.5006 to 0.5519) | 0.408 (0.3711 to 0.4449) | 0.1947 (0.1344 to 0.255) | 0.4509 (0.4112 to 0.4905) |
ISnew | 0.5511 (0.5226 to 0.5796) | 0.4476 (0.4083 to 0.487) | 0.2557 (0.1917 to 0.3197) | 0.4623 (0.4214 to 0.5032) |
IPold | 0.3849 (0.3651 to 0.4048) | 0.2267 (0.2111 to 0.2422) | 0.0846 (0.0781 to 0.0911) | 0.2146 (0.1968 to 0.2325) |
IPnew | 0.3648 (0.3425 to 0.3871) | 0.2115 (0.1937 to 0.2293) | 0.0782 (0.0693 to 0.0871) | 0.2102 (0.192 to 0.2283) |